Steatorrhea is not a really a condition but a symptom in which fecal matter is frothy, foul-smelling and floats because of a high fat content. It is common in malabsorption syndromes. Steatorrhea is excessive excretion of fecal fat.
The underlying condition causes of steatorrhea include:Crohn's disease, maldigestion secondary to pancreatic or bile duct obstruction, and "short-gut" syndrome secondary to surgical resection, bypass, or congenital anomaly.
When small intestinal disease is suspected as the source of steatorrhea, function tests of intestinal absorption may be performed. D-xylose absorption will test proximal small bowel function. The Schilling tests (I and II) and bile acid breath tests assess distal small bowel function. The Schilling test with antibiotics (part III) and the bile acid breath test will facilitate a diagnosis of bacterial overgrowth. Structural abnormalities of the small bowel are detected by barium studies and/or biopsy. Less common causes of steatorrhea require further diagnostic testing (e.g.duodenal aspiration for Giardia, serum gastrin for Zollinger-Ellison disease, etc.).
In cases of chronic pancreatitis, a marked reduction in the secretion of pancreatic enzymes leads to steatorrhea. The first requirement in the treatment of steatorrhea is the ingestion of potent enzymes. A total of 30,000 units of lipase should be consumed with each meal. A few mouthfuls of the meal should be consumed priorto ingesting any enzymes in orderto protect enzymes against the harmful effects of gastric acid.
Therapy with potent pancreatic enzymes usually reduces the passage of bulky stools and permits significant weight gain. If this therapy is ineffective, however, the next important step in treatment of steatorrhea is the protection of enzymes against gastric acid. This protection can be achieved by either reducing the secretion of hydrogen ions with an H2 blocker (while continuing therapy with the same potent enzymes) or by ingesting pH-sensitive enteric-coated pancreatic enzymes. These enteric-coated preparations do not release enzymes until the milieu becomes alkaline (presumably within the duodenum).
The pH-sensitive enteric-coated enzymes may fail either because the pH within the stomach becomes alkaline prematurely (thereby permitting the premature release of enzymes which may then be exposed to a subsequent acid milieu) or because the size of the microspheres that contain the enzymes may be too large to be emptied in timely fashion from the stomach.
If pancreatic enzyme therapy with either an H2 blocker or enteric-coated preparation does not provide improvement, the next step is to decrease dietary fat to 50gm per day and to substitute medium-chain triglycerides (which do not require hydrolysis prior to absorption) for some dietary fat.
If steatorrhea persists, there may be excessive gastric secretion that requires a more potent H2 blocker. There appear to be factors other than acid that may prevent effectiveness of pancreatic enzymes. For example, even when sufficient pancreatic enzymes are instilled directly into the duodenum, steatorrhea may not be fully eliminated.
Stool fats (or fecal fats, or fecal lipids) are fats that are excreted in the feces. When secretions from the pancreas and liver are adequate, emulsified dietary fats are almost completely absorbed in the small intestine. When a malabsorption disorder or another cause disrupts this process, excretion of fat in the stool increases.
Most people with cystic fibrosis have difficulty absorbing dietary fat, which in turn leads to steatorrhea. Cystic fibrosis interferes with the ability of the pancreas to secrete digestive enzymes: fat is normally broken down by lipase, a digestive enzyme that is produced and secreted by the pancreas.
Both qualitative and quantitative tests are used to identify excessive fecal fat. The qualitative test involves staining a specimen of stool with a special dye, then examining it microscopically for evidence of malabsorption, such as undigested muscle fiber and various fats. The quantitative test involves drying and weighing a 72-hour stool specimen, then using an extraction technique to separate the fats, which are subsequently evaporated and weighed. This measurement of the total output of fecal fat per 24 hours in a three-day specimen is the most reliable test for steatorrhea.
This test requires a 72-hour stool collection. The patient should abstain from alcohol during this time and maintain a high-fat diet (100gm/day) for three days before the test, and during the collection period. The patient should call the laboratory for instructions on how to collect the specimen.